SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-028872
Filing Date
2023-06-07
Accepted
2023-06-07 21:53:35
Documents
2
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3493
2 EXHIBIT 24.1 brhc20054174_ex24-1.htm EX-24.1 9832
  Complete submission text file 0001140361-23-028872.txt   14755
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210
Business Address
Segal Assaf (Reporting) CIK: 0001979156 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39990 | Film No.: 231000549